Genvor Inc, classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 22 October 2026, brought 5 filings signed by 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Insider buying of Genvor Inc has been absent for the past year. Typically, a trade is published a median of 5 days after it takes place. Section 16 rules allow two business days to file each Form 4.
With 5 filings in twelve months, the company is quieter than the median of 8 filings across the 277 companies we follow on the same exchange.
In the same sector, recent insider purchases at Fuller H B Co and Gold.com, Inc. also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2021 · cache
21 of 21 declarations
Genvor Inc is a company listed on the XNAS market. It operates in the financial sector, providing various services and products to clients.
Purchases our model currently ranks for the recommendations list.
All recommendations